Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-26 @ 1:10 AM
NCT ID:
NCT05256134
Pre Assignment Details:
A total of 25 amyloid-positive, cognitively unimpaired participants at risk for or at the earliest stages of Alzheimer's Disease (AD) were randomized in a 1:1 ratio to receive either gantenerumab or placebo in this study.
Recruitment Details:
Participants took part in this study at 12 investigative centers in Australia, Canada, and the United States from 19 April 2022 to 13 March 2023.
Study:
NCT05256134
Study Brief:
Results Section:
NCT05256134